PUT/FRESENIUS/20/0.1/20.09.24 Share Price

Warrant

DE000GQ569R3

Market Closed - BOERSE MUENCHEN 11:55:30 05/07/2024 pm IST
0.008 EUR 0.00% Intraday chart for PUT/FRESENIUS/20/0.1/20.09.24
Current month-11.11%
1 month-27.27%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/24/05 0.008 0.00%
04/24/04 0.008 +33.33%
03/24/03 0.006 -25.00%
02/24/02 0.008 -11.11%
01/24/01 0.009 0.00%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 11:55 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
Issuer Goldman Sachs
WKN GQ569R
ISINDE000GQ569R3
Date issued 20/09/2023
Strike 20
Maturity 20/09/2024 (76 Days)
Parity 10 : 1
Emission price 0.03
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.134
Lowest since issue 0.006
Delta-0.05x
Omega 8.602
Premium31.86x
Gearing171.18x
Moneyness 0.6873
Difference Strike -9.1
Difference Strike %-45.50%
Spread 0.02
Spread %74.07%
Theoretical value 0.0170
Implied Volatility 54.92 %
Total Loss Probability 91.78 %
Intrinsic value 0.000000
Present value 0.0170
Break even 19.83 €
Theta-0x
Vega0x
Rho-0x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.1 EUR
Average target price
37.26 EUR
Spread / Average Target
+28.03%
Consensus